Effect of MMX® mesalamine coadministration on the pharmacokinetics of amoxicillin, ciprofloxacin XR, metronidazole, and sulfamethoxazole: results from four randomized clinical trials

Overview of attention for article published in Drug Design, Development and Therapy, May 2014

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (69th percentile)

Mentioned by

twitter: 2 X users
facebook: 1 Facebook page

googleplus: 1 Google+ user

Citations

dimensions_citation: 10 Dimensions

Readers on

mendeley: 63 Mendeley

Summary X Facebook Google+ Dimensions citations

So far, Altmetric has seen 1 Google+ post.

Dove Medical Press (NZ) Ltd, 16 Jul 2014

Background: MMX® mesalamine is a once daily oral 5-aminosalicylic acid formulation, effective in induction... Background: MMX®…